Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA new Revision: v3.7.0 is added to the study's history and Revision: v3.6.6 is removed, reflecting an update to the record's version history.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision version v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the visible history.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, indicating an update to the study documentation. The prior revision v3.6.4 is removed from the visible history, reflecting an updated QC/metadata revision.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history shows Revision: v3.6.4 added, replacing the previous v3.6.3, indicating an update to the page's revision metadata.SummaryDifference0.1%

- Check86 days agoChange DetectedA new record revision (v3.6.3) is added to the history and a prior revision (v3.6.2) is removed, updating the version history and provenance of the record.SummaryDifference0.1%

- Check93 days agoChange DetectedA newer revision entry, v3.6.2, was added to the study record history, replacing the previous v3.6.0. This signals an update to the record version.SummaryDifference0.1%

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.